ea0048p11 | Poster Presentations | SFEEU2017
McGowan Barbara
, Roux Carel Le
, Astrup Arne
, Fujioka Ken
, Greenway Frank
, Lau David
, Van Gaal Luc
, Ortiz Rafael Violante
, Wilding John
, Skjoth Trine
, Pi-Sunyer Xavier
Background: The 3-year part of this trial investigated the effect of liraglutide 3.0 mg, as an adjunct to diet+exercise, in delaying onset of T2D (primary endpoint) in adults with prediabetes and obesity (BMI ≥30 kg/m2) or overweight (≥27 kg/m2) with comorbidities.Methods: Participants were randomised 2:1 to once-daily subcutaneous liraglutide 3.0 mg or placebo plus 500 kcal/day deficit diet and 150...